NOAVARAN DAROUI KIMIA CO. LIMITED SEEKS TO MAKE AFRICA AS A KEY EXPORT HUB AS THEY EXHIBIT AT THE 23RD MEDEXPO KENYA 2023

Posted on :Friday , 9th June 2023

 Noavaran Daroui Kimia Co., A trusted leader pharmaceutical company in producing novel oncology medicines in IRAN located in Tehran City, backed with experienced top investors and pharmaceutical executives. Noavaran Daroui Kimia Co. as a pioneer in the regions’ pharmaceutical industry, vowed to fulfill the patient’s need to the best in class novel, generic medicines. They take care of patient’s hope to improve their health via further growing portfolio and strengthening the international presence.

SANYAR TAJHIZ MAJDI TAKES UP A BOOTH AT 23RD MEDEXPO KENYA 2023

Posted on :Friday , 9th June 2023

Sanyar Tajhiz Majdi Company was founded in 2020 with the mission of advancing and developing innovative medical tools to alleviate patients' pain. Our company strives to pave the way for simplified treatments by merging the fields of medical science and engineering, ultimately making significant contributions to the enhancement of public health.

DAROU DARMAN ARANG HAS REGISTERED TO PARTICIPATE IN 23RD MEDEXPO KENYA 2023

Posted on :Friday , 9th June 2023

PAZHOUHESH GOSTARAN TAGHZIEH ASAN WILL PARTICIPATE IN AFRICAN MARKET AT 23RD MEDEXPO KENYA 2023

Posted on :Friday , 9th June 2023

Since 2016 TA Co. originally started its evidence-based activities in functional foods and nutritional powders formulation and production according to main nutritional requirements of the society. During their activities, they have always had a dynamic and systematic approach, with research and experience of their scientists in order to achieve production  and create a basket  of products that meet the nutritional needs of individuals in Iranian society, based on research and development activities and the application of up-to-date nutritional knowledge and technologies.

PARAND DAROU CO. IS PREPARED TO ENTER THE EAST AFRICAN REGION BY EXHIBITING AT THE 23RD MEDEXPO KENYA 2023

Posted on :Friday , 9th June 2023

 Parand Darou Pharmaceutical Company, as a knowledge-based company, started its activity with the production of narcotic APIs in 1385. Parand Company is the second company in the private sector that received a license to produce narcotic products from the Food and Drug Organization of Iran, and with the extraction Opioid raw materials has been able to produce effective medicinal substances such as Codeine Phosphate, Noscapine, Thebaine, Papaverine and Oxycodone and in addition to meeting the needs of domestic customers, it has exported its products to the world market.